Profile
ASMB VRTX VRNA REGN ALNY ARGX
Company Name Assembly Biosciences, Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $238.22M $108.04B $72.68B $67.32B $58.93B $50.06B
Employees 0.07K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Jason A. Okazaki Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
ASMB VRTX VRNA REGN ALNY ARGX
Quant Rating Score 1 3 1 4 2 4
Quant Rating Strong Sell Neutral Strong Sell Buy Sell Buy
Trading
ASMB VRTX VRNA REGN ALNY ARGX
Last Close $31.05 $425.57 $106.91 $651.8 $456.04 $818.5
High 52 $31.05 $516.74 $106.91 $843.6 $491.09 $849.46
Low 52 $8.12 $366.54 $34.98 $482.92 $224.58 $532.27
Price vs. 52 Week High 0 % -17.64 % 0 % -22.74 % -7.14 % -3.64 %
Price vs. 52 Week Low 282.39 % 16.1 % 205.63 % 34.97 % 103.06 % 53.78 %
Total Return
ASMB VRTX VRNA REGN ALNY ARGX
1 Month Return 33.15 % 5.52 % 0.11 % 8.63 % -0.07 % 2.31 %
3 Month Return 68.75 % -7.91 % 1.64 % 16.63 % 13.5 % 21.48 %
6 Month Return 118.97 % -15.08 % 47 % 7.63 % 75.81 % 25.99 %
9 Month Return 125 % -9.52 % 81.26 % -2.26 % 66.1 % 24.48 %
YTD Return 96.77 % 5.68 % 130.21 % -8.5 % 93.8 % 33.09 %
1 Year Return 83.84 % -9.67 % 205.63 % -22.74 % 66.49 % 37.43 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ASMB VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.41 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -147.93 % 4.25 % 5.97 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
ASMB VRTX VRNA REGN ALNY ARGX
Asset Growth -12.9 % 53.91 %
Gross Profit Growth 168.02 % 5941.02 %
Revenue Growth 298.16 % -
Revenue 3 Year 3434.2 % -23.33 %
Revenue 5 Year 943.78 % 290254.46 %
Revenue 10 Year - -
EBIT Growth 29.74 % -162.64 %
Net Income Growth 34.38 % -218.96 %
Net Income 3 Yeari Growth Per Share -139.78 % -126.38 %
Net Income 5 Yeari Growth Per Share -140.41 % 33.14 %
Net Income 10 Yeari Growth Per Share -96.86 % -7.28 %
Operating Income Growth 29.74 % -127.96 %
Operating Cash Flow Growth (CFG) -324.76 % -143.33 %
Operating 3 Year CFG -324.17 % -166.57 %
Operating 5 Year CFG -255.23 % 55.51 %
Operating 10 Year CFG -297.91 % 41.1 %
EPS Growth 50 % -200 %
EPS Diluted Growth 50 % -215.05 %
Book Value Per Share -38.12 % -24.01 %
Share Holder 3 Year Equity Growth Per Share 53.04 % 0.26 %
Share Holder 5 Year Equity Growth Per Share -28.67 % -25.62 %
Share Holder 10 Year Equity Growth Per Share -33.61 % -72.3 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 31.9 % 139.05 %
Free Cash Flow Growth -327.43 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ASMB VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM 99.86 % 86.11 % 95.15 % 85.39 % 51.22 % 65.82 %
Return on Assets TTM -48.23 % 15.13 % -14.17 % 11.4 % 0.9 % 15.06 %
Return on Equity TTM -149.01 % 22.14 % -38.66 % 15.31 % 26.13 % 18.96 %
Return on Capital Employed TTM -129.96 % 19.72 % -10.74 % 10.32 % 8.03 % 5.04 %
Net Income Per EBT TTM 99.81 % 83.16 % 111.3 % 88.98 % -136.38 % 237.3 %
EBT Per Ebit TTM 89.7 % 111.48 % 130.22 % 139.5 % -12.07 % 147.38 %
EBIT Per Revenue TTM -184.25 % 34.36 % -25.27 % 25.89 % 8.25 % 13.47 %
Cash Flow To Debt Ratio TTM -1936.48 % 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Receivables Turnover TTM - 6.03 2.55 2.51 3.33 1.91
Payables Turnover TTM 0.09 3.59 3.13 2.3 2.69 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 4.2 2.26
Fixed Asset Turnover TTM 787.1 % 431.08 % 8642.22 % 284.82 % 463.12 % 5009.77 %
Asset Turnover TTM 29.24 % 47.51 % 38.7 % 35.47 % 66.16 % 31.97 %
Operating Cash Flow Per Share TTM -7.29 14.98 -0.85 48.94 2.02 5.67
Free Cash Flow Per Share TTM -7.29 13.63 -0.85 40.09 1.68 5.58
Cash Per Share TTM 979.38 % 2486.48 % 511.44 % 8148.65 % 2072.79 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -236.43 % 33.68 % -32.7 % 35.59 % 8.28 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 100.75 % 81.92 % 83.26 % 98.47 %
Cash Flow Coverage Ratios TTM -1936.48 % 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Price To Free Cash Flows Ratio TTM -4.27 30.87 -995.27 16.2 266.2 126.04
Price To Operating Cash Flows Ratio TTM -4.26 28.12 -126.33 13.32 222.27 143.95
Price Cash Flow Ratio TTM -4.26 28.12 -126.33 13.32 222.27 143.95
Income Statement (TTM)
ASMB VRTX VRNA REGN ALNY ARGX
Revenue $0.03B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0.03B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 99.55% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.05B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.04B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -6.69 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
ASMB VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $2.59B $0.03B
Total Liabilities $0.09B $6.12B $0.27B $8.41B $4.23B $0.7B
Total Equity $0.03B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0.07B $6.65B $0.02B $15.42B $1.8B $1.93B
Total Debt $0B $1.75B $0.12B $2.7B $2.74B $0.04B
Total Assets $0.12B $22.53B $0.47B $37.76B $4.3B $6.2B
Cash Flow Statement (TTM)
ASMB VRTX VRNA REGN ALNY ARGX
Net Income $-0.04B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.05B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 34.2999
AARD Aardvark Therapeutics, Inc. Common Stock 10.37
ABCL AbCellera Biologics Inc. 5.36
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.765
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.17
ABPWW 0.0144
ABSI Absci Corporation 4.105
ABUS Arbutus Biopharma Corporation 4.57
ABVC ABVC BioPharma, Inc. 2.97
ABVX Abivax SA American Depositary Shares 98.88
ACAD ACADIA Pharmaceuticals Inc. 22.365
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.73
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.105
ACIU AC Immune SA 3.17
ETFs With Exposure to ASMB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00037 335.82
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.09
VXF Vanguard Extended Market Index Fund 0.00363 211.02
IWC iShares Micro-Cap ETF 0.03273 154.73
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00025 114.06
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00025 114.04
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0.02096 44.22
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00018 53.28
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00018 53.27
VBINX Vanguard Balanced Index Fund Investor Shares 0.00018 53.27
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
AVUV Avantis U.S. Small Cap Value ETF 0 97.83
GERM ETFMG Treatments, Testing and Advancements ETF 0.09 19.1577
DFAU Dimensional US Core Equity Market ETF 0 46.685
DFAT Dimensional U.S. Targeted Value ETF 0.000039 57.05
DFAS Dimensional U.S. Small Cap ETF 0.000234 67.87
VTSAX Vanguard Total Stock Market Index Fund 0.00037 163.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00363 160.7
VITSX Vanguard Total Stock Market Index Fund 0.00037 163.27
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000175428 16.54
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00363 160.71
JKJ iShares Morningstar Small-Cap ETF 0 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 57.23
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VTS.AX Vanguard US Total Market Shares Index ETF 0.00018 513.2
VEMPX Vanguard Extended Market Index InstlPlus 0.00363 396.57
FESM 0.02 37.23
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00037 306.27
Unlock